UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.079

Sortiert nach

Duloxetine vs. placebo in patients with painful diabetic neuropathy

Pain (Amsterdam), 2005-07, Vol.116 (1-2), p.109

2005

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

Pain (Amsterdam), 2005-12, Vol.119 (1-3), p.5

2005

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetine

Journal of clinical psychopharmacology, 2004-08, Vol.24 (4), p.389-399

2004

Link zum Volltext

Verfügbarkeit prüfen

Adverse pregnancy outcomes with SSRIs

American journal of obstetrics and gynecology, 2007, Vol.196 (1), p.e25-e25

Goldstein, David J., MD, PhD

2007

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial

The journal of clinical psychiatry, 2002-04, Vol.63 (4), p.308

2002

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial

The journal of clinical psychiatry, 2002-03, Vol.63 (3), p.225

2002

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

Journal of psychiatric research, 2002-11, Vol.36 (6), p.383-390

2002

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine for Patients with Diabetic Peripheral Neuropathic Pain: A 6-Month Open-Label Safety Study

Pain medicine (Malden, Mass.), 2006-09, Vol.7 (5), p.373-385

2006

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine in the long-term treatment of major depressive disorder

The journal of clinical psychiatry, 2003-10, Vol.64 (10), p.1237

2003

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine in treatment of anxiety symptoms associated with depression

Depression and anxiety, 2003-01, Vol.18 (2), p.53-61

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of first-trimester fluoxetine exposure on the newborn

Obstetrics and gynecology (New York. 1953), 1997-05, Vol.89 (5), p.713-718

1997

Link zum Volltext

Verfügbarkeit prüfen

Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18

Oncogene, 1997-07, Vol.15 (3), p.265-274

1997

Link zum Volltext

Verfügbarkeit prüfen

Dose-response study of the analgesic effect of Lanepitant in patients with painful diabetic neuropathy

Clinical neuropharmacology, 2001-01, Vol.24 (1), p.16-22

2001

Link zum Volltext

Verfügbarkeit prüfen

A double‐blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

Arthritis and rheumatism, 2004-09, Vol.50 (9), p.2974-2984

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of Duloxetine on Painful Physical Symptoms Associated With Depression

Psychosomatics (Washington, D.C.), 2004-01, Vol.45 (1), p.17-28

2004

Link zum Volltext

Verfügbarkeit prüfen

Olanzapine-exposed pregnancies and lactation : Early experience

Journal of clinical psychopharmacology, 2000-08, Vol.20 (4), p.399-403

2000

Link zum Volltext

Verfügbarkeit prüfen

Microcystic adnexal carcinoma: A distinct clinicopathologic entity

Cancer, 1982-08, Vol.50 (3), p.566-572

1982

Link zum Volltext

Verfügbarkeit prüfen

Effects of third trimester fluoxetine exposure on the newborn

Journal of clinical psychopharmacology, 1995-12, Vol.15 (6), p.417-420

GOLDSTEIN, D. J

1995

Link zum Volltext

Verfügbarkeit prüfen

Lanepitant, an NK-1 Antagonist, in Migraine Prevention

Cephalalgia, 2001-03, Vol.21 (2), p.102-106

2001

Link zum Volltext

Verfügbarkeit prüfen

Psychotropic medications during pregnancy: risk to the fetus

JAMA : the journal of the American Medical Association, 1993-11, Vol.270 (18), p.2177; author reply 2178

Tueth, M J

1993

Link zum Volltext

Verfügbarkeit prüfen

Study of the analgesic effect of lanepitant in patients with osteoarthritis pain

Clinical pharmacology and therapeutics, 2000-04, Vol.67 (4), p.419-426

2000

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression

The International journal of eating disorders, 1999-01, Vol.25 (1), p.19-27

1999

Link zum Volltext

Verfügbarkeit prüfen

Human placental alkaline phosphatase differs from that of other species

Nature (London), 1979-08, Vol.280 (5723), p.602-605

1979

Link zum Volltext

Verfügbarkeit prüfen

Tumor necrosis factor α interferes with the cell cycle of normal and papillomavirus-immortalized human keratinocytes

Cancer research (Chicago, Ill.), 1996-05, Vol.56 (10), p.2452-2457

1996

Link zum Volltext

Verfügbarkeit prüfen

Determination of pregnancy outcome risk rates after exposure to an intervention

Clinical pharmacology and therapeutics, 2001-01, Vol.69 (1), p.7-13

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.079

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.039)
Mit Volltextzugriff
(878)

Publikationsform

Artikel
(1.079)

Sprache

Englisch
(1.079)
Japanisch
(217)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Duloxetine vs. placebo in patients with painful diabetic neuropathy

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetine

Adverse pregnancy outcomes with SSRIs

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

Duloxetine for Patients with Diabetic Peripheral Neuropathic Pain: A 6-Month Open-Label Safety Study

Duloxetine in the long-term treatment of major depressive disorder

Duloxetine in treatment of anxiety symptoms associated with depression

Effects of first-trimester fluoxetine exposure on the newborn

Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18

Dose-response study of the analgesic effect of Lanepitant in patients with painful diabetic neuropathy

A double‐blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

Effects of Duloxetine on Painful Physical Symptoms Associated With Depression

Olanzapine-exposed pregnancies and lactation : Early experience

Microcystic adnexal carcinoma: A distinct clinicopathologic entity

Effects of third trimester fluoxetine exposure on the newborn

Lanepitant, an NK-1 Antagonist, in Migraine Prevention

Psychotropic medications during pregnancy: risk to the fetus

Study of the analgesic effect of lanepitant in patients with osteoarthritis pain

Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression

Human placental alkaline phosphatase differs from that of other species

Tumor necrosis factor α interferes with the cell cycle of normal and papillomavirus-immortalized human keratinocytes

Determination of pregnancy outcome risk rates after exposure to an intervention

Aktive Filter

Suchergebnisse filtern